Home/Markets/Connecticut
CT Live

Connecticut Cannabis
The Overregulated Experiment

THC potency caps. Mandatory 30-day retesting. A retaliatory inspection scandal. The first major brand already exited the state. Monthly sales have flatlined at $18–25M while Massachusetts to the north offers lower prices and fewer restrictions. Connecticut is a $290 million market that should be twice its size.

$12.57/g
Median flower $/g
−15%
Avg price decline (2023–25)
$7.44/g
Transaction avg (DCP)
$79K
Median trade area income
Data Coverage
What we track in Connecticut
Triple-source menu coverage across Connecticut’s dispensary network, validated against DCP sales data reported through the BioTrack seed-to-sale system. Connecticut’s small market size and regulatory complexity make competitive intelligence especially critical — every pricing decision is magnified.
35
Cities
38,956
Menu Items
61
Licensed Retailers
3.6M
State Population
AVAILABLE
Demographic Intelligence
Census-tract level · Connecticut dispensary trade areas
Median household income, age distribution, education levels, employment rates, and home values for the neighborhoods surrounding every dispensary. Available in Radius Briefs and Quarterly Reports.
The Connecticut Story
A $290 million market squeezed between overregulation and Massachusetts price competition.
Connecticut launched adult-use sales in January 2023 with strict THC caps, complex testing mandates, and a cautious rollout. Two and a half years later, monthly sales have flatlined, the first major operator has exited, and the state’s own cannabis ombudsman calls the regulatory environment “challenging.”
2012 — Medical Legalization
Connecticut legalizes medical cannabis with a limited dispensary model. By 2021, the medical program generates $10–12M/month — a solid base for a 3.6M-population state.
2021 — RERACA Signed
Governor Lamont signs the Responsible and Equitable Regulation of Adult-Use Cannabis Act. The framework includes THC potency caps (30% flower, 60% concentrates), social equity joint ventures, and DCP oversight. Equity structure requires joint ventures between social equity license holders and established companies.
2023 — Launch Year
Adult-use sales begin January 10, 2023 with nine hybrid retailers. First year: $274M combined ($145M adult-use + $129M medical). By December, monthly combined sales reach a record $27.5M. But medical sales begin declining immediately as patients convert to recreational.
2024 — Stagnation
Sales reach $293M (+7% over 2023), but monthly adult-use growth flatlines at $18M/month. Medical sales drop $21M year-over-year. Average per-item price falls from $39.70 to $33.67. Massachusetts offers lower prices, drawing Connecticut customers across the border. Tax revenue: $49.4M (FY24).
2025 — Brand Exits and Regulatory Backlash
Acreage Holdings exits Connecticut, selling three Botanist dispensaries. Ayr Wellness reportedly considering departure. DCP commissioner forced to apologize for retaliatory inspection of a cultivator who testified about overregulation. Total sales slip to ~$290M despite record 8.6M items sold — price compression outpacing volume growth. THC caps raised slightly (35% flower, 70% concentrates) in October.
Government Data
Department of Consumer Protection (DCP)
Connecticut’s DCP publishes monthly sales data through BioTrack. The state’s cannabis tax is calculated by THC content and product type — roughly 9.4% on a typical flower eighth. Medical marijuana is not taxed.
~$290M (2025)
Total cannabis sales, down slightly from $293M in 2024 despite selling a record 8.6M items (+1M over prior year). More product for less money = prices are compressing. 2023 first year: $274M ($145M adult-use + $129M medical).
Source: DCP / MJBizDaily
~$70M Cumulative Tax
Total adult-use cannabis tax collected since January 2023 launch. FY24: $49.4M including cannabis tax, state sales tax, municipal sales tax, and licensing fees. Compare to Massachusetts’ $1B+ cumulative — the scale gap is enormous.
Source: CT Mirror / DCP
61 Retailers
Licensed dispensaries (29 hybrid medical/recreational, remainder recreational only, 1 medical-only). Launched with just 9 hybrid retailers in January 2023. Market growing from a small base, but monthly sales have flatlined since early 2024.
Source: DCP / MJBizDaily
$39.70 → $33.67
Average per-item price from 2023 to 2025, a 15% decline. Yet Connecticut remains more expensive than Massachusetts, which drives cross-border shopping northward. The price premium is a regulatory artifact, not a market signal.
Source: DCP / MJBizDaily
THC Caps
Recreational flower capped at 35% THC (raised from 30% in Oct 2025), concentrates at 70% (raised from 60%). Mandatory 30-day retesting for potency — a 20% natural variation can trigger costly product recalls. Medical patients exempt from caps.
Source: RERACA / CT News Junkie
Brand Exits
Acreage Holdings (Botanist) sold 3 dispensaries and exited CT in June 2025. Ayr Wellness reportedly considering departure. The state’s own cannabis ombudsman acknowledged the “challenging business environment.” Operators cite overregulation as the primary barrier.
Source: CT News Junkie / CT Insider
Cross-State Context
Connecticut is more expensive than Massachusetts. That’s not supposed to happen.
Massachusetts is larger, more mature, and significantly cheaper. Connecticut is newer, smaller, more regulated, and still more expensive. That price inversion drives customers north.

See Massachusetts’ $8B mature market →

Intelligence Products
Connecticut market intelligence, built for your segment
Every product includes CT’s full pricing data plus regional context across the New England corridor. Connecticut’s tight license caps and high price floor create a market where regulatory dynamics matter more than competition.

Dispensary Operator Stack

For CT dispensary operators
  • Competitive pricing across all CT cities
  • Hartford & New Haven metro deep-dives
  • Category-level margins vs. state medians
  • DCP regulatory compliance tracking

Brand & Cultivator Stack

For brands selling into CT
  • Shelf presence by brand across CT dispensaries
  • Category pricing vs. New England benchmarks
  • Distribution gap analysis by region
  • Small-market brand positioning strategy

Investor & Analyst Stack

For investors evaluating CT
  • High-price, low-volume market analysis
  • DCP licensing pipeline & expansion impact
  • Revenue-per-store trend analysis
  • New England corridor dynamics (MA/VT/ME)

$290 million. 61 dispensaries. Every pricing decision moves the needle.

Hyperlocal competitive intelligence for Connecticut operators navigating the smallest and most heavily regulated market in our dataset. In a market this concentrated, data is the edge.

Get Intelligence →

Get Your Competitive Intelligence

6.0M+ menu items • 8,374+ dispensaries • 19 markets

Your information is confidential. We never share data.

Press & media inquiries welcome — inquiries@rootinsights.ai